Brief: Cytrx Announces $7.0 Million Registered Direct Offering
CytRx Corp CYTR.O :
* CYTRX ANNOUNCES $7.0 MILLION REGISTERED DIRECT OFFERING
* CYTRX - ENTERED PURCHASE AGREEMENTS WITH CERTAIN
INSTITUTIONAL
INVESTORS TO SELL IN REGISTERED DIRECT OFFERING 5.6 MILLION
SHARES AT PRICE OF $1.25/SHARE
Source text for Eikon: ID:nPn5kJwHa
Further company coverage: CYTR.O
Recent news on LadRx
See all newsBrief: Ladrx Issues 2024 Update To Shareholders
Brief: LadRx Completes Non-Dilutive Financing Transaction For Up To $11 Mln With Xoma Corporation
Brief: LadRx Intends To Apply To List Stock On Nasdaq Under Symbol 'LADX'
Brief: LadRx Announces Review Of Strategic Alternatives, Provides Corporate Updates
Brief: CytRx Highlights Orphazyme's Update On Productive Meeting With FDA Regarding Arimoclomol In Niemann-Pick Disease Type C